Study Title
A multi-center, adaptive, prospective, randomized trial evaluating the efficacy and safety of antithrombotic strategies in patients with Covid-19 following discharge. (Activ)
Purpose
To determine if a blood thinner medication can prevent blood clots from developing in patients recently hospitalized with Covid-19.
Eligibility
Study Process
Trial Details
Investigator:
Anthony Stuart, MD
IRB:
WIRB
IRB Number:
Trial Type:
Drug
Sponsor:
Duke University
Contact Information:
(318) 212-8130